Author Index: P

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Pabiniak, C.
• OPTIMAL COLORECTAL CANCER SCREENING FOR A HIGHER-RISK POPULATION: THE CASE OF NORTHEASTERN PENNSYLVANIA
Padula, W.
• WHAT IS THE MOST COST-EFFECTIVE STRATEGY FOR TREATING CHRONIC MYELOID LEUKEMIA AFTER IMATINIB LOSES PATENT EXCLUSIVITY IN THE UNITED STATES?
• SOCIETAL AND POLICY IMPLICATIONS FOR MEDICALLY NECESSARY SERVICES AND PREVENTIVE CARE IN THE U.S. TRANSGENDER POPULATION: A COST-EFFECTIVENESS ANALYSIS
• COST MINIMIZATION OF AFTER HOURS POSTOPERATIVE CARE FOR TRANSPLANT RECIPIENTS
• COMPARING EVIDENCE-BASED DECISION TOOLS TO CHECKLISTS FOR THE PREVENTION OF HOSPITAL-ACQUIRED CONDITIONS: A VALUE OF INFORMATION ANALYSIS
Pagán, J. A.
• USING SIMULATION MODELING TO COMPARE ALTERNATIVE LIFESTYLE APPROACHES AND PREVENT CARDIOVASCULAR DISEASE
Painter, P.
• IMPROVED SURVIVAL WITH TELEPHONIC CARE MANAGEMENT
Palefsky, J.
• SCREENING HIGH-RISK MEN FOR ANAL CARCINOGENSIS: MODEL DEVELOPMENT AND POLICY ANALYSIS
Paltiel, A. D.
• COMPARATIVE AND COST-EFFECTIVENESS ANALYSES OF LABORATORY-BASED AND NON-LABORATORY-BASED CARDIOVASCULAR RISK SCREENING IN UZBEKISTAN
• THE COST-EFFECTIVENESS OF TARGETING HIV PRE-EXPOSURE PROPHYLAXIS BASED ON PARTNER TREATMENT STATUS IN MEN WHO HAVE SEX WITH MEN IN THE US
Pandey, K.
• PATTERNS OF COST-RELATED MEDICATION NON-ADHERENCE AMONG OLDER PATIENTS AT HIGH RISK OF HOSPITALIZATION
Pandey, K.
• FINANCIAL BURDEN AND IMPOVERISHMENT DUE TO CARDIOVASCULAR MEDICINES IN LOW AND MIDDLE INCOME COUNTRIES, AN ANALYSIS WITH ILLUSTRATION FROM INDIA
Pandey, N.
• ESTIMATING LIPID MANAGEMENT GUIDELINES' RISK VALUE OF A LIFE YEAR ON TREATMENT
Pandya, A.
• MODELING THE COST EFFECTIVENESS OF NEUROIMAGING-BASED TREATMENT OF ACUTE STROKE PATIENTS WITH UNKNOWN STROKE ONSET TIME
• COMPARATIVE AND COST-EFFECTIVENESS ANALYSES OF LABORATORY-BASED AND NON-LABORATORY-BASED CARDIOVASCULAR RISK SCREENING IN UZBEKISTAN
• EXTRACTING OPERATING CHARACTERISTICS THAT ARE “BAKED INTO” DISEASE ASSOCIATION MEASURES
• METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
Panoch, J.
• A COMPARISON OF NEONATAL MORBIDITY AND MORTALITY ESTIMATES PROVIDED BY OBSTETRICIANS AND NEONATOLOGISTS IN PERIVIABLE COUNSELING
Papasavas, P.
• SIMULATION TRAINING TO IMPROVE CLINICAL DECISION-MAKING BY SURGICAL RESIDENTS
Parand, A.
• JOURNEY TO VACCINATION: A QUALITATIVE EXPLORATION OF HOW BELIEFS, PERCEPTIONS AND PREVIOUS EXPERIENCES INFLUENCE VACCINATION BEHAVIOR
Park, S. S.
• COST-EFFECTIVENESS ANALYSIS OF CYP2B6 GENETIC TESTING TO INFORM EFAVIRENZ DOSE REDUCTION FOR INITIAL HIV THERAPY
Parsons, J.
• ASSESSING THE COST-EFFECTIVENESS OF HBA1C TESTING IN THE DIAGNOSIS OF TYPE II DIABETES AND THE IMPACT OF AN IMPERFECT DIAGNOSTIC REFERENCE STANDARD
Partin, M.
• THE EFFECTS OF SHARED DECISION MAKING ON CANCER SCREENING: A SYSTEMATIC REVIEW
Partington, A.
• COMPARATIVE EFFECTIVENESS RESEARCH TO INFORM QUALITY IMPROVEMENT USING LINKED COSTS, OUTCOMES, AND PROCESS DATA
Patel, P.
• HIV SEXUAL TRANSMISSION RISK: ASSESSING THE EFFECTS OF COMBINING PREVENTION STRATEGIES
Patel, S.
• THE EFFECTS OF SHARED DECISION MAKING ON CANCER SCREENING: A SYSTEMATIC REVIEW
Patel, V.
• PROMOTING AWARENESS AND IMPLEMENTATION OF ADVANCE CARE PLANNING: A CONTENT ANALYSIS OF DECISION AIDS
Paternina, A.
• EPIDEMIOLOGICAL AND ECONOMIC IMPACT OF MONOVALENT AND PENTAVALENT ROTAVIRUS VACCINES IN LOW AND MIDDLE INCOME COUNTRIES: A COST-EFFECTIVENESS MODELING ANALYSIS
Patrick-Miller, L.
• PATIENT-SPECIFIC PHARMACOGENOMIC RESULTS DELIVERED VIA A GENOMIC PRESCRIBING DECISION SUPPORT SYSTEM STRONGLY INFLUENCE PHYSICIAN MEDICATION DECISION-MAKING AND PRESCRIBING BEHAVIORS
Paulden, M.
• THE IMPACT OF ESTIMATING MORTALITY RATES IN COST-EFFECTIVENESS ANALYSIS.: A SIMULATION STUDY
• THE LAMBDA COMPLEX: KNOWING YOUR PLACE IN THE THRESHOLD MATRIX
• ADVANCING METHODS OF HTA: OPTIMISING MONITORING TESTS TO MEET VALUE TARGETS
Payne, K.
• VALUING PREFERENCES FOR THE PROCESS AND OUTCOME OF CLINICAL GENETICS SERVICES: A PILOT STUDY
• THE PAY-OFF TIME FRAMEWORK: AN APPLICATION TO A NATIONAL CLINICAL GUIDELINE ON HYPERTENSION
• DEVELOPING A STATED CHOICE EXPERIMENT TO UNDERSTAND PREFERENCES FOR INFORMATION PROVISION IN AN EXPANDED NEWBORN BLOODSPOT SCREENING PROGRAMME
• INVESTIGATING THE FRAMING OF RISK ATTRIBUTES IN A DISCRETE CHOICE EXPERIMENT: AN APPLICATION OF EYE-TRACKING AND THINK ALOUD
Paz, A.
• PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS
Peay, H.
• COMPARING BEST WORST SCALING AND CONJOINT ANALYSIS TO MEASURE CAREGIVER PREFERENCES FOR THE BENEFITS AND RISKS OF EMERGING TREATMENTS FOR DUCHENE MUSCULAR DYSTROPHY
Pechlivanoglou, P.
• THE IMPACT OF ESTIMATING MORTALITY RATES IN COST-EFFECTIVENESS ANALYSIS.: A SIMULATION STUDY
• COST-EFFECTIVENESS ANALYSIS OF PALLIATIVE TEAM CARE FOR PATIENTS NEARING END-OF-LIFE
• META-ANALYSIS OF PREFERENCE-BASED QUALITY OF LIFE VALUES IN CORONARY HEART DISEASE
• WOUND INTERDISCIPLINARY TEAMS (WIT): A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL
• COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL
Pedersen, K.
• TRADE-OFFS IN CERVICAL CANCER SCREENING – BALANCING DETECTED CANCER PRECURSORS AND RESOURCE USE
Pedroza, R.
• STEM CELL DERIVED BETA CELL TRANSPLANTATION: AN EXAMPLE FOR MODELLING THE COST OF MANUFACTURING NEW AND IMMATURE HEALTHCARE TECHNOLOGIES FOR EARLY PRIORITIZATION OF RESEARCH AND RESOURCES
Peek, M.
• SYMPOSIUM: SO A MODELER, AN ECONOMIST, A SHARED DECISION MAKING EXPERT AND A PAIR OF PATIENT EXPERTS WALK INTO A CONFERENCE ROOM...
Peinado, S.
• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?
Pennington, M. W.
• IMPROVING THE EXTRAPOLATION OF SURVIVAL DATA; HOW SHOULD WE EXPLOIT ADDITIONAL DATA?
Penson, D.
• BEYOND SEQUENCING FOR MEDICAL PRACTICE PATTERN ANALYSIS: THE USE OF HIERARCHICAL CLUSTER ANALYSIS WITH AN APPLICATION TO URETEROLITHIASIS
Perez Figueroa, R.
• USABILITY TESTING OF “INFORMEDTOGETHER”, A WEB-BASED DECISION AID TO FACILITATE SHARED ADVANCE DIRECTIVE PLANNING FOR SEVERE COPD
Perez, R.
• PERCEPTION OF SURGICAL SITE INFECTION RISK FACTORS FOR SPINE SURGERY VARIES BY OPERATIVE TEAM ROLE
Perk, S.
• ECONOMIC AND CLINICAL IMPACT OF SWITCHING FROM ANTIMUSCARINICS TO MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
Perkins, S. M.
• PRESENTING STOOL TESTING AS THE DEFAULT OPTION FOR COLORECTAL CANCER SCREENING: RESULTS OF A RANDOMIZED TRIAL
• USING CONJOINT ANALYSIS TO ASSESS THE RELATIVE INFLUENCE OF RESUSCITATION PREFERENCES ON OBSTETRICAL MANAGEMENT OF PERIVIABLE DELIVERIES
Perzynski, A. T.
• PREDICTORS OF BEHAVIORAL INTERVENTION ATTENDANCE AND CLINICAL APPOINTMENT SHOW RATE FOR INDIVIDUALS WITH SERIOUS MENTAL ILLNESS AND DIABETES
• HEALTH RISK ASSESSMENT SOFTWARE FOR EVERYONE: TESTING THE ASSOCIATION OF NUMERACY WITH ENGAGEMENT, PERCEIVED USEFULNESS AND SATISFACTION
• INTRODUCTION TO STRUCTURAL EQUATION MODELING
Peterson, J.
• STRATEGIES TO PREEMPTIVELY GENOTYPE PATIENTS FOR INDIVIDUALIZED MEDICINE
Petrosyan, V.
• HOW FAMILY-BASED COUNSELING/EDUCATION CAN IMPACT THE HEALTH OF PATIENTS WITH TUBERCULOSIS IN ARMENIA, 2013
Pflug, E.
• THINKING FORWARD: THE TIME ORIENTATION OF PATIENTS MAKING TREATMENT DECISIONS
Pham, B.
• THE IMPACT OF ESTIMATING MORTALITY RATES IN COST-EFFECTIVENESS ANALYSIS.: A SIMULATION STUDY
• COST-EFFECTIVENESS ANALYSIS OF PALLIATIVE TEAM CARE FOR PATIENTS NEARING END-OF-LIFE
• COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL
Phillips, M. H.
• STATISTICAL MODELING AND SENSITIVITY ANALYSIS WITH SPARSE DATA IN OROPHARYNGEAL CANCER: CHALLENGES AND SOLUTIONS
Phung, O.
• PREVALENCE OF CLINICAL GUIDELINE-DIRECTED TREATMENT INTENSIFICATION IN DIABETES MELLITUS: A SYSTEMATIC REVIEW
Pieterse, A. H.
• BREAST CANCER PATIENTS' INVOLVEMENT IN DECISIONS: PERSPECTIVE AND TYPE OF ADJUVANT THERAPY MATTER
• REASON FOR ENCOUNTER: A MISSED OPPORTUNITY FOR SHARED DECISION MAKING
• PARTNERING OR PERSUADING: DECISION MAKING DURING CONSULTATIONS BETWEEN BREAST CANCER PATIENTS AND MEDICAL ONCOLOGISTS
Pignone, M.
• EXAMINING THE EFFECTIVENESS OF DIFFERENT ELEMENTS OF A READMISSION PREVENTION BUNDLE
Pignone, M.
• QUANTIFYING THE DISUTILITY OF TAKING PILLS FOR PREVENTING HEART DISEASE
Pillemer, K.
• COMMUNICATION AND TREATMENT PREFERENCES AMONG OLDER ADULTS WITH CHRONIC MUSCULOSKELETAL PAIN
Pilote, L.
• “IT'S LIKE JAYWALKING ACROSS A BUSY STREET WITH YOUR EYES CLOSED, YOU'RE TAKING A CHANCE”: RISK COMMUNICATION AND VALUES CLARIFICATION IN A RADIATION ONCOLOGY CLINIC
Piret, J.
• STEM CELL DERIVED BETA CELL TRANSPLANTATION: AN EXAMPLE FOR MODELLING THE COST OF MANUFACTURING NEW AND IMMATURE HEALTHCARE TECHNOLOGIES FOR EARLY PRIORITIZATION OF RESEARCH AND RESOURCES
Pitt, A.
• COST-EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY COMPARED WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ALONE IN MILD HEART FAILURE
Pluye, P.
• “IT'S LIKE JAYWALKING ACROSS A BUSY STREET WITH YOUR EYES CLOSED, YOU'RE TAKING A CHANCE”: RISK COMMUNICATION AND VALUES CLARIFICATION IN A RADIATION ONCOLOGY CLINIC
Pogach, L.
• RAPID ASSESSMENT OF MODELLING SOFTWARE BY END-USERS: THE EXAMPLE OF GLYCEMIC MANAGEMENT OPTIONS FOR TYPE 2 DIABETES
Pohl, E.
• OPTIMIZING BREAST CANCER MAMMOGRAPHY SCREENING POLICIES CONSIDERING WOMEN'S ADHERENCE BEHAVIORS
Polanczyk, C. A.
• COST-EFFECTIVENESS OF DIAGNOSTIC TESTS FOR ASSESSING STABLE CHEST PAIN: SHOULD CARDIAC MAGNETIC RESONANCE AND CORONARY COMPUTED TOMOGRAPHY BE REIMBURSED BY A MIDDLE-INCOME COUNTRY'S PUBLIC HEALTHCARE SYSTEM?
Politi, M.
• SMDM CORE COURSE: INTRODUCTION TO SHARED DECISION MAKING AND PATIENT DECISION AIDS
Pollack, L.
• IN VITRO FERTILIZATION INSURANCE COVERAGE AND CHANCES OF A LIVE BIRTH
Portnoy, A.
• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)
Postma, M.
• META-ANALYSIS OF PREFERENCE-BASED QUALITY OF LIFE VALUES IN CORONARY HEART DISEASE
Postmus, D.
• THE APPLICATION OF CONTINUOUS-TIME SEMI-MARKOV MODELS IN HEALTH ECONOMIC DECISION MAKING: A CASE STUDY IN HEART FAILURE DISEASE MANAGEMENT
Potter, B. J.
• IMPACT OF INTERVENTIONS TO REDUCE BLEEDING ON THE COST-EFFECTIVENESS OF STEMI MANAGEMENT STRATEGIES IN NON-URBAN COMMUNITIES
Power, M.
• THE CLINICAL, PSYCHO-SOCIAL AND COST IMPACTS OF PERFORMING ACTIVE SURVEILLANCE ON KNOWN MRSA+ PATIENTS ADMITTED TO MEDICAL-SURGICAL UNITS
Prabhu, V. S.
• EVALUATING DIFFERENT APPROACHES TO ESTIMATING TREATMENT COSTS FROM A RANDOMIZED CLINICAL TRIAL WITH INCOMPLETE FOLLOW-UP
Prakash, R.
• REAL-TIME ESTIMATES OF NET CLINICAL BENEFIT OF ANTITHROMBOTIC THERAPY FOR PATIENTS WITH ATRIAL FIBRILLATION
Prashanth, H.
• THE EFFECT OF A VOICE-SITE ON INFORMED CHOICE FOR WOMEN CONSIDERING CERVICAL CANCER SCREENING IN RURAL INDIA: A PHASE II CONTROLLED TRIAL
Pritchard, K. I.
• COST-EFFECTIVENESS OF HEPATITIS B VIRUS SCREENING BEFORE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH EARLY STAGE BREAST CANCER
Prokopyev, O.
• MEDICAL DECISION MAKING PROBLEMS WITH LARGE POLICY SPACES: WHY MARKOV DECISION PROCESSES TRUMP SIMULATION
Prosser, L. A.
• SYMPOSIUM: WHAT SHOULD THE ROLE OF CEA BE IN HEALTH POLICY AND MEDICAL DECISION MAKING?
• SYMPOSIUM: APPLYING STATED-PREFERENCE METHODS AMONG DIVERSE PATIENT GROUPS
• THE MARGINAL COST-EFFECTIVENESS OF CHILDHOOD VACCINATION COVERAGE
Pullenayegum, E.
• UNDERESTIMATION OF VARIANCE OF MEAN UTILITIES DERIVED FROM MULTI-ATTRIBUTE UTILITY INSTRUMENTS: THE USE OF MULTIPLE IMPUTATION AS A POTENTIAL SOLUTION
Pulley, J.
• STRATEGIES TO PREEMPTIVELY GENOTYPE PATIENTS FOR INDIVIDUALIZED MEDICINE
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z